Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Udoamaka Ezuruike"'
Autor:
Udoamaka Ezuruike, Mian Zhang, Amita Pansari, Mailys De Sousa Mendes, Xian Pan, Sibylle Neuhoff, Iain Gardner
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 7, Pp 805-821 (2022)
Abstract The Simcyp Simulator is a software platform for population physiologically‐based pharmacokinetic (PBPK) modeling and simulation. It links in vitro data to in vivo absorption, distribution, metabolism, excretion and pharmacokinetic/pharmaco
Externí odkaz:
https://doaj.org/article/023b01530b6a4f1c98ca11daa48493f6
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
Adequate prediction of fetal exposure of drugs excreted by the kidney requires the incorporation of time-varying renal function parameters into a pharmacokinetic model. Published data on measurements of fetal urinary production rate (FUPR) and creati
Externí odkaz:
https://doaj.org/article/ecf8171541d141cf91b7b4a12c9ab394
Autor:
Udoamaka Ezuruike, Mian Zhang, Amita Pansari, Mailys De Sousa Mendes, Xian Pan, Sibylle Neuhoff, Iain Gardner
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. 11:805-821
The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation. It links in vitro data to in vivo absorption, distribution, metabolism, excretion and pharmacokinetic/pharmacodynamic out
Publikováno v:
Frontiers in pediatrics. 10
Adequate prediction of fetal exposure of drugs excreted by the kidney requires the incorporation of time-varying renal function parameters into a pharmacokinetic model. Published data on measurements of fetal urinary production rate (FUPR) and creati
Publikováno v:
Drug Metabolism and Pharmacokinetics. 35:S87
Autor:
Helen Humphries, Udoamaka Ezuruike, Maurice Dickins, Sibylle Neuhoff, Iain Gardner, Karen Rowland Yeo
Publikováno v:
Clinical Pharmacology and Therapeutics
Current formulations of combined oral contraceptives (COC) containing ethinylestradiol (EE) have ≤35 μg due to increased risks of cardiovascular diseases (CVD) with higher doses of EE. Low-dose formulations however, have resulted in increased inci